Recent developments in dystonia

Current Opinion in Neurology

Volumn 28, Issue 4, 2015, Pages 400-405

  Jinnah, Hyder A ^a   Teller, Jan K ^b   Galpern, Wendy R ^c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Dystonia Medical Research Foundation   (United States)

^c NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

blepharospasm; spasmodic dysphonia; torticollis; writer's cramp

Indexed keywords

BOTULINUM TOXIN; LEVODOPA;

BRAIN DEPTH STIMULATION; CLINICAL CLASSIFICATION; DYSTONIA; GENE ISOLATION; GENETIC SCREENING; HUMAN; REVIEW; SYSTEMATIC REVIEW (TOPIC); CLASSIFICATION; DYSTONIC DISORDERS; PHENOTYPE;

DYSTONIA; DYSTONIC DISORDERS; HUMANS; PHENOTYPE;

EID: 84941212340     PISSN: 13507540     EISSN: 14736551     Source Type: Journal    
DOI: 10.1097/WCO.0000000000000213     Document Type: Review

References (49)

1. Tiderington E, Goodman EM, Rosen AR, et al. How long does it take to diagnose cervical dystonia? J Neurol Sci 2013; 335:72-74.
2. Creighton FX, Hapner ER, Klein AM, et al. Diagnostic delays in spasmodic dysphonia: a call for clinician education. J Voice 2015. (in press).
3. Macerollo A, Superbo M, Gigante AF, et al. Diagnostic delay in adult-onset dystonia: data from an Italian movement disorder center. J Clin Neurosci 2015; 22:608-610.
4. Jog M, Chouinard S, Hobson D, et al. Causes for treatment delays in dystonia and hemifacial spasm: a Canadian survey. Can J Neurol Sci 2011; 38:704-711.
5. Beghi E, Regio V, Papantonio A, et al. Reliability of clinical diagnosis of dystonia. Neuroepidemiology 2014; 43:213-219.
6. Klein C, Fahn S. Translation of Oppenheim's 1911 paper on dystonia. Mov Disord 2013; 28:851-862.
7. Albanese A, Bhatia K, Bressman SB, et al. Phenomenology and classification of dystonia: a consensus update. Mov Disord 2013; 28:863-873.
8. Jinnah HA, Albanese A. The new classification for the dystonias: why was it needed and how was it accomplished? Mov Disord Clin Pract 2014; 1:280-284.
9. Berman BD, Jinnah HA. Dystonia: five new things. Neurol Clin Pract 2015. (in press).
10. Balint B, Bhatia K.P. Isolated and combined dystonia syndromes:an update on new genes and their phenotypes. Eur J Neurol 2015; 22:610-617.
11. Fahn S. The varied clinical expressions of dystonia. Neurol Clin 1984; 2:541-554.
12. Marsden CD. Dystonia: the spectrum of the disease. In: Yahr MD, editor. The basal ganglia. New York: Raven Press; 1976. pp. 351-367.
13. Ozelius LJ, Hewett JW, Page CE, et al. The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein. Nat Genet 1997; 17:40-48.
14. Fuchs T, Gavarini S, Saunders-Pullman R, et al. Mutations in the THAP1 gene are responsible for DYT6 primary torsion dystonia. Nat Genet 2009; 41:286-288.
15. Xiao J, Uitti RJ, Zhao Y, et al. Mutations in CIZ1 cause adult onset primary cervical dystonia. Ann Neurol 2012; 71:458-469.
16. Charlesworth G, Plagnol V, Holmstrom KM, et al. Mutations in ANO3 cause dominant craniocervical dystonia: ion channel implicated in pathogenesis. Am J Hum Genet 2012; 91:1041-1050.
17. Fuchs T, Saunders-Pullman R, Masuho I, et al. Mutations in GNAL cause primary torsion dystonia. Nat Genet 2013; 45:88-92.
18. Vemula SR, Puschmann A, Xiao J, et al. Role of G-alpha(olf) in familial and sporadic adult-onset primary dystonia. Hum Mol Genet 2013; 22:2510-2519.
19. Zech M, Gross N, Jochim A, et al. Rare sequence variants in ANO3 and GNAL in a primary torsion dystonia series and controls. Mov Disord 2014; 29:143-147.
20. Stamelou M, Charlesworth G, Cordivari C, et al. The phenotypic spectrum of DYT24 due to ANO3 mutations. Mov Disord 2014; 29:928-934.
21. Miyamoto R, Koizumi H, Morino H, et al. DYT6 in Japan-genetic screening and clinical characteristics of the patients. Mov Disord 2014; 29:278-280.
22. Dufke C, Sturm M, Schroeder C, et al. Screening of mutations in GNAL in sporadic dystonia patients. Mov Disord 2014; 29:1193-1196.
23. Xiromerisiou G, Houlden H, Scarmeas N, et al. THAP1 mutations and dystonia phenotypes: genotype phenotype correlations. Mov Disord 2012; 27:1290-1294.
24. LeDoux MS, Xiao J, Rudzinska M, et al. Genotype-phenotype correlations in THAP1 dystonia: molecular foundations and description of new cases. Parkinsonism Relat Disord 2012; 18:414-425.
25. Miao J, Wan XH, Sun Y, et al. Mutation screening of GNAL gene in patients with primary dystonia from Northeast China. Parkinsonism Relat Disord 2013; 19:910-912.
26. Erro R, Bhatia KP, Hardy J. GNAL mutations and dystonia. J Am Med Assoc Neurol 2014; 71:1052-1053.
27. Ziegan J, Wittstock M, Westenberger A, et al. Novel GNAL mutations in two German patients with sporadic dystonia. Mov Disord 2014; 29:1833-1834.
28. Groen JL, Ritz K, Tanck MW, et al. Is TOR1A a risk factor in adult-onset primary torsion dystonia? Mov Disord 2013; 28:827-831.
29. Dobricic V, Kresojevic N, Westenberger A, et al. De novo mutation in the GNAL gene causing seemingly sporadic dystonia in a Serbian patient. Mov Disord 2014; 29:1190-1193.
30. Delanty N, Goldstein DB. Diagnostic exome sequencing: a new paradigm in neurology. Neuron 2013; 80:841-843.
31. Biesecker LG, Green RC. Diagnostic clinical genome and exome sequencing. N Engl J Med 2014; 370:2418-2425.
32. Meneret A, Ahmar-Beaugendre Y, Rieunier G, et al. The pleiotropic movement disorders phenotype of adult ataxia-telangiectasia. Neurology 2014; 83:1087-1095.
33. Charlesworth G, Mohire MD, Schneider SA, et al. Ataxia telangiectasia presenting as dopa-responsive cervical dystonia. Neurology 2013; 81:1148-1151.
34. Saunders-Pullman R, Raymond D, Stoessl AJ, et al. Variant ataxia-telangiec-tasia presenting as primary-appearing dystonia in Canadian Mennonites. Neurology 2012; 78:649-657.
35. Verhagen MM, Abdo WF, Willemsen MA, et al. Clinical spectrum of ataxia-telangiectasia in adulthood. Neurology 2009; 73:430-437.
36. Klein CJ, Middha S, Duan X, et al. Application of whole exome sequencing in undiagnosed inherited polyneuropathies. J Neurol Neurosurg Psychiatry 2014; 85:1265-1272.
37. Pyle A, Smertenko T, Bargiela D, et al. Exome sequencing in undiagnosed inherited and sporadic ataxias. Brain 2015; 138:276-283.
38. Novarino G, Fenstermaker AG, Zaki MS, et al. Exome sequencing links corticospinal motor neuron disease to common neurodegenerative disorders. Science 2014; 343:506-511.
39. Zoons E, Dijkgraaf MG, Dijk JM, et al. Botulinum toxin as treatment for focal dystonia: a systematic review of the pharmaco-therapeutic and pharmaco-economic value. J Neurol 2012; 259:2519-2526.
40. Hallett M, Benecke R, Blitzer A, Comella CL. Treatment of focal dystonias with botulinum neurotoxin. Toxicon 2009; 54:628-633.
41. Simpson DM, Blitzer A, Brashear A, et al. Assessment: botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2008; 70:1699-1706.
42. Mills KA, Starr PA, Ostrem JL. Neuromodulation for dystonia: target and patient selection. Neurosurg Clin N Am 2014; 25:59-75.
43. Moro E, Gross RE, Krauss JK. What's new in surgical treatments for dystonia? Mov Disord 2013; 28:1013-1020.
44. Vidailhet M, Jutras MF, Grabli D, Roze E. Deep brain stimulation for dystonia. J Neurol Neurosurg Psychiatry 2012; 84:1029-1040.
45. Jinnah HA, Factor S. Diagnosis and treatment of dystonia. Jankovic J, editor. Neurologic clinics: Elsevier; 2015.
46. Thenganatt MA, Jankovic J. Treatment of dystonia. Neurotherapeutics 2014; 11:139-152.
47. Jankovic J. Medical treatment of dystonia. Mov Disord 2013; 28:1001-1012.
48. van Egmond ME, Kuiper A, Eggink H, et al. Dystonia in children and adolescents: a systematic review and a new diagnostic algorithm. J Neurol Neurosurg Psychiatry 2014. (In press).
49. Shashi V, McConkie-Rosell A, Rosell B, et al. The utility of the traditional medical genetics diagnostic evaluation in the context of next-generation sequencing for undiagnosed genetic disorders. Genet Med 2014; 16:176-182.